123 related articles for article (PubMed ID: 27127393)
41. Current evidence supporting fertility and pregnancy among young survivors of breast cancer.
Meneses K; Holland AC
J Obstet Gynecol Neonatal Nurs; 2014; 43(3):374-81. PubMed ID: 24689363
[TBL] [Abstract][Full Text] [Related]
42. Cardiac effects of adjuvant therapy for early breast cancer.
Theodoulou M; Seidman AD
Semin Oncol; 2003 Dec; 30(6):730-9. PubMed ID: 14663774
[TBL] [Abstract][Full Text] [Related]
43. Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline.
De Vos FY; van Laarhoven HW; Laven JS; Themmen AP; Beex LV; Sweep CG; Seynaeve C; Jager A
Crit Rev Oncol Hematol; 2012 Nov; 84(2):252-60. PubMed ID: 22795229
[TBL] [Abstract][Full Text] [Related]
44. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
[TBL] [Abstract][Full Text] [Related]
45. Self-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials.
Schmidt ME; Wiskemann J; Ulrich CM; Schneeweiss A; Steindorf K
Acta Oncol; 2017 Apr; 56(4):618-627. PubMed ID: 28084890
[TBL] [Abstract][Full Text] [Related]
46. Relative mortality rates from incident chronic diseases among breast cancer survivors--a 14 year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007.
Ording AG; Boffetta P; Garne JP; Nyström PM; Cronin-Fenton D; Frøslev T; Silliman R; Sørensen HT; Lash TL
Eur J Cancer; 2015 Apr; 51(6):767-75. PubMed ID: 25765753
[TBL] [Abstract][Full Text] [Related]
47. Relationship between severity of symptoms and quality of life in patients with breast cancer receiving adjuvant hormonal therapy.
Ochayon L; Zelker R; Kaduri L; Kadmon I
Oncol Nurs Forum; 2010 Sep; 37(5):E349-58. PubMed ID: 20797943
[TBL] [Abstract][Full Text] [Related]
48. Electrocardiography changes during adjuvant breast cancer therapy: incidence and risk factors.
Elme A; Saarto T; Tötterman KJ; Utrianen M; Kautiainen H; Järvenpää S; Tenhuen M; Blomqvist C
Anticancer Res; 2013 Nov; 33(11):4933-9. PubMed ID: 24222132
[TBL] [Abstract][Full Text] [Related]
49. Skeletal health in postmenopausal survivors of early breast cancer.
Mackey JR; Joy AA
Int J Cancer; 2005 May; 114(6):1010-5. PubMed ID: 15645435
[TBL] [Abstract][Full Text] [Related]
50. Does the Risk of Metabolic Syndrome Increase in Thyroid Cancer Survivors?
Kim MH; Huh JY; Lim DJ; Kang MI
Thyroid; 2017 Jul; 27(7):936-943. PubMed ID: 28393666
[TBL] [Abstract][Full Text] [Related]
51. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
Mothes AR; Runnebaum M; Runnebaum IB
J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
[TBL] [Abstract][Full Text] [Related]
52. Quality of life of breast cancer survivors: the impact of hormonal replacement therapy.
Durna EM; Crowe SM; Leader LR; Eden JA
Climacteric; 2002 Sep; 5(3):266-76. PubMed ID: 12419085
[TBL] [Abstract][Full Text] [Related]
53. Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls.
Lohmann AE; Ennis M; Taylor SK; Goodwin PJ
Breast Cancer Res Treat; 2017 Jul; 164(2):451-460. PubMed ID: 28444534
[TBL] [Abstract][Full Text] [Related]
54. Estrogen replacement therapy after breast cancer: a 12-year follow-up.
Peters GN; Fodera T; Sabol J; Jones S; Euhus D
Ann Surg Oncol; 2001 Dec; 8(10):828-32. PubMed ID: 11776498
[TBL] [Abstract][Full Text] [Related]
55. Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy.
Koppelmans V; Schagen SB; Poels MM; Boogerd W; Seynaeve C; van der Lugt A; Breteler MM
Eur J Cancer; 2011 Nov; 47(17):2531-6. PubMed ID: 21745734
[TBL] [Abstract][Full Text] [Related]
56. Adjuvant hormonal therapy for premenopausal women with breast cancer.
Emens LA; Davidson NE
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):486S-94S. PubMed ID: 12538505
[TBL] [Abstract][Full Text] [Related]
57. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].
Coudert B; Chaplain G; Milan C; Janoray P
Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
59. [Metabolic syndrome in postmenopausal breast cancer survivors].
Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
[TBL] [Abstract][Full Text] [Related]
60. Nutritional advice to breast cancer survivors.
Pasanisi P; Villarini A; Bruno E; Raimondi M; Gargano G; Berrino F
Support Care Cancer; 2010 May; 18 Suppl 2():S29-33. PubMed ID: 19626345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
